Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

10. Geographic Information (Details - Geographic regions) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Sales revenue from geographical territories	$ 4,144,000	$ 2,574,000	$ 7,747,000	$ 4,985,000
Increase (decrease) in sales revenue	$ 1,570,000		$ 2,762,000
Percent change in sales revenue	61.00%		55.00%
Sales Revenue, Segment [Member] \| United States [Member]
Sales revenue from geographical territories	$ 2,268,000	1,697,000	$ 4,127,000	3,070,000
Increase (decrease) in sales revenue	$ 571,000		$ 1,057,000
Percent change in sales revenue	34.00%		34.00%
Sales Revenue, Segment [Member] \| Latin America [Member]
Sales revenue from geographical territories	$ 754,000	0	$ 1,323,000	0
Increase (decrease) in sales revenue	$ 754,000		$ 1,323,000
Percent change in sales revenue	100.00%		100.00%
Sales Revenue, Segment [Member] \| Europe and Other [Member]
Sales revenue from geographical territories	$ 1,122,000	$ 877,000	$ 2,297,000	$ 1,915,000
Increase (decrease) in sales revenue	$ 245,000		$ 382,000
Percent change in sales revenue	28.00%		20.00%